U.S drug regulator: Warns Sun Pharma
The United States Food and Drug Administration (USFDA) has issued a warning letter to Sun Pharmaceuticals as the company was found violating manufacturing norms in its Cranbury facility in New Jersey. Sun Pharma has stated that the FDA has withheld approval of pending new drug applications listing the facility as the manufacturer.
